Hashida H, Coffey R
J Gastrointest Oncol. 2022; 13(1):149-162.
PMID: 35284114
PMC: 8899738.
DOI: 10.21037/jgo-21-528.
Ni Q, Chen Z, Zheng Q, Xie D, Li J, Cheng S
Cancer Sci. 2020; 111(5):1500-1513.
PMID: 31997489
PMC: 7226218.
DOI: 10.1111/cas.14331.
Ojo D, Rodriguez D, Wei F, Bane A, Tang D
Sci Rep. 2019; 9(1):6624.
PMID: 31036830
PMC: 6488675.
DOI: 10.1038/s41598-019-43006-y.
Ma Y, Chen Y, Li Y, Grun K, Berndt A, Zhou Z
Oncotarget. 2018; 9(18):14084-14098.
PMID: 29581829
PMC: 5865655.
DOI: 10.18632/oncotarget.23505.
Boonyaratanakornkit V, Hamilton N, Marquez-Garban D, Pateetin P, McGowan E, Pietras R
Mol Cell Endocrinol. 2017; 466:51-72.
PMID: 29146555
PMC: 5878997.
DOI: 10.1016/j.mce.2017.11.010.
A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus.
Yadav A, Kumar B, Lang J, Teknos T, Kumar P
Oncogene. 2017; 36(46):6374-6382.
PMID: 28745314
PMC: 5690845.
DOI: 10.1038/onc.2017.245.
High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
Kumar B, Brown N, Swanson B, Schmitt A, Old M, Ozer E
Oncotarget. 2016; 7(14):18665-77.
PMID: 26919244
PMC: 4951318.
DOI: 10.18632/oncotarget.7625.
Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.
Clark N, Friel A, Pru C, Zhang L, Shioda T, Rueda B
Cancer Biol Ther. 2016; 17(3):262-71.
PMID: 26785864
PMC: 4847980.
DOI: 10.1080/15384047.2016.1139240.
SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer.
Tian J, Liu Y, Zhu B, Tian Y, Zhong R, Chen W
Oncotarget. 2015; 6(35):37750-7.
PMID: 26498691
PMC: 4741962.
DOI: 10.18632/oncotarget.5647.
PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.
Lin S, May E, Chang J, Hu R, Wang L, Chan H
Cell Mol Life Sci. 2015; 72(12):2395-409.
PMID: 25596698
PMC: 11397629.
DOI: 10.1007/s00018-014-1831-9.
Synthesis and biological characterisation of 18F-SIG343 and 18F-SIG353, novel and high selectivity σ2 radiotracers, for tumour imaging properties.
Nguyen V, Pham T, Fookes C, Berghofer P, Greguric I, Arthur A
EJNMMI Res. 2013; 3(1):80.
PMID: 24330526
PMC: 3878827.
DOI: 10.1186/2191-219X-3-80.
Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene.
Wu M, Tu T, Huang Y, Cao Y
BMC Cancer. 2013; 13:44.
PMID: 23374247
PMC: 3567939.
DOI: 10.1186/1471-2407-13-44.
Identification and characterization of alternative exon usage linked glioblastoma multiforme survival.
Sadeque A, Serao N, Southey B, Delfino K, Rodriguez-Zas S
BMC Med Genomics. 2012; 5:59.
PMID: 23206951
PMC: 3548711.
DOI: 10.1186/1755-8794-5-59.
Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity.
Ahmed I, Rohe H, Twist K, Craven R
J Biol Chem. 2010; 285(32):24775-82.
PMID: 20538600
PMC: 2915713.
DOI: 10.1074/jbc.M110.134585.
The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung.
Savci-Heijink C, Kosari F, Aubry M, Caron B, Sun Z, Yang P
Am J Pathol. 2009; 174(5):1629-37.
PMID: 19342368
PMC: 2671252.
DOI: 10.2353/ajpath.2009.080778.
PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.
Rohe H, Ahmed I, Twist K, Craven R
Pharmacol Ther. 2008; 121(1):14-9.
PMID: 18992768
PMC: 2659782.
DOI: 10.1016/j.pharmthera.2008.09.006.
Comparative proteomics analysis of human gastric cancer.
Li W, Li J, Qu Y, Chen X, Qin J, Gu Q
World J Gastroenterol. 2008; 14(37):5657-64.
PMID: 18837081
PMC: 2748199.
DOI: 10.3748/wjg.14.5657.
Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features.
Aviel-Ronen S, Coe B, Lau S, da Cunha Santos G, Zhu C, Strumpf D
Proc Natl Acad Sci U S A. 2008; 105(29):10155-60.
PMID: 18632575
PMC: 2465804.
DOI: 10.1073/pnas.0709618105.
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon A, Seiwert T
Cancer Res. 2008; 68(1):132-42.
PMID: 18172305
PMC: 2767335.
DOI: 10.1158/0008-5472.CAN-07-1998.
Establishment and characterization of a human large cell lung cancer cell line with neuroendocrine differentiation.
Sharifzadeh S, Owji S, Pezeshki A, Malek-Hoseini Z, Kumar P, Ghayumi S
Pathol Oncol Res. 2004; 10(4):225-30.
PMID: 15619644
DOI: 10.1007/BF03033765.